Product NDC: | 24338-120 |
Proprietary Name: | ERYTHROMYCIN |
Non Proprietary Name: | Erythromycin |
Active Ingredient(s): | 250 mg/1 & nbsp; Erythromycin |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 24338-120 |
Labeler Name: | Arbor Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA062746 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120110 |
Package NDC: | 24338-120-13 |
Package Description: | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (24338-120-13) |
NDC Code | 24338-120-13 |
Proprietary Name | ERYTHROMYCIN |
Package Description | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (24338-120-13) |
Product NDC | 24338-120 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Erythromycin |
Dosage Form Name | CAPSULE, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20120110 |
Marketing Category Name | ANDA |
Labeler Name | Arbor Pharmaceuticals, Inc. |
Substance Name | ERYTHROMYCIN |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |